OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE:NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces its results for the second quarter and half year 2015. A presentation of the results by Nordic Nanovector’s senior management team will take place today at 8:30am CEST in Oslo, details are below. Luigi Costa, CEO of Nordic Nanovector, said: “Following the great start to 2015, which saw the Company compl